Adam Alessio (Michigan State University, USA)
Prof Adam Alessio is a professor in the departments of Computational Mathematics, Science, and Engineering, Biomedical Engineering, and Radiology at Michigan State University. His research is focused on non-invasive quantification of disease through advanced imaging algorithms and integrated data analysis.
Prof Alessio’s research group solves clinically motivated research problems at the intersection of imaging and medical decision-making. Current efforts centre on translational medical research projects for topics including machine learning for quantitative diagnostics, cardiac perfusion estimation, quantitative PET and CT imaging, radiation dose optimization, and system modelling. Prior to joining Michigan State University, Prof Alessio was a professor of Radiology at the University of Washington. He received his Ph.D. in Electrical Engineering at the University of Notre Dame and post-doctoral training in nuclear medicine physics at the University of Washington. He is the author of over 70 peer-reviewed publications, holds 6 patents, and has grant funding from the National Institutes of Health and the medical imaging industry to advance non-invasive cardiac and cancer imaging.
Antony Gee (King’s College London, UK)
Prof Tony Gee is a Professor of PET and Radiochemistry in the Division of Imaging Sciences at King’s College London. His research interests have spanned various aspects of radiopharmaceutical science, from the development of novel chemistry for PET imaging, to establishing PET imaging in clinical research and pioneering the discovery, development and application of: (a) new labelling methods for short-lived positron emitting radionuclides (11C, 18F, 13N, 15O); (b) radiochemistry instrumentation (e.g. microfluidics, flow chemistry, automation); and (c) novel in vivo molecular imaging probes (e.g. 5-HT4, 5-HT6, dopamine transporter, PDE4, I2, RAGE, CYP12B, P2X7 etc) and their translation to preclinical and human studies. He obtained a BSc(Hons) in Chemistry at the University of Sussex (1985), and his PhD in Radiopharmaceutical Organic Chemistry at Uppsala University, Sweden (1991). He has previously worked as the Director of PET Chemistry at the Guy’s and St Thomas’ Hospitals Clinical PET centre, UMDS, London, the Aarhus University Hospital PET Centre in Aarhus Denmark and at GlaxoSmithKline. He is active in national, European and International radiopharmaceutical research, training and education initiatives in the field and is currently the President of the International Society of Radiopharmaceutical Sciences (SRS), Chair of UK PET Chemistry, and previously a member of the Royal Society of Chemistry Radiochemistry group and Chair of the European Association of Nuclear Medicine Drug Development Committee.
Guobao Wang (UC Davis, USA)
Prof Wang works in the advancement of PET imaging using computational methods and clinical translation. His research commonly integrates high-resolution dynamic data acquisition with the design of advanced computational imaging algorithms to derive quantitative imaging biomarkers. His research group translates quantitative PET imaging techniques to improve clinical diagnosis, prognosis and therapy response assessment in various diseases, in close collaboration with clinicians. He is a NIH/NCI Paul Calabresi Clinical Oncology K12 Scholar and a NIH/NIBIB Trailblazer Award recipient.
Oliver Langer (Medical University Vienna, Austria)
Dr. Langer is an Associate Professor at the Medical University of Vienna in Austria (Department of Clinical Pharmacology). He is also a Senior Scientist at the AIT Austrian Institute of Technology GmbH. He has studied pharmacy at the University of Vienna (Austria) and has received his PhD degree from the Karolinska Institute in Sweden. In his research, he uses preclinical and clinical PET to address different questions related to drug disposition. He has developed several innovative PET protocols to measure the activity of various ABC and SLC transporters in different organs (e.g. brain, liver, eye and lungs) and has translated many of these protocols from rodents to healthy human volunteers and patients. He is author of 132 articles in peer-reviewed scientific journals and has a Hirsch (h) index of 34.
Suleman Surti (University of Pennsylvania, USA)
Prof Surti is a Research Associate Professor in the Physics and Instrumentation group in the Department of Radiology at the University of Pennsylvania. He obtained his Ph.D. in Physics at the University of Pennsylvania and continued his post-doctoral work and faculty appointment in PET imaging research at Penn. Prof Surti’s general research interest is in PET imaging, ranging from detector and system development through data corrections to image analysis and imaging protocol optimization. In a career spanning over twenty years he has been involved in the development, optimization, and evaluation of several PET scanners developed at the University of Pennsylvania as well as new commercial systems ranging from small-animal PET through application-specific PET (brain, breast, proton) to whole-body PET (Non-TOF, TOF, long axial field-of-view). His current research projects involve the development of a dedicated breast PET/DBT system, new scatter correction methods, task based image optimization for modern PET/CT systems, and new whole-body PET system design and development.